Ntusi et al. reported reduced inflammatory markers and myocardial inflammation after anti-TNF-alpha treatment in a cohort with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis [41]. The gene discussed is TNF; the disease is psoriatic arthritis.